Detalles de la búsqueda
1.
Single fraction high-dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: toxicities and early outcomes from a single institutional experience.
J Contemp Brachytherapy
; 11(5): 399-408, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31749847
Resultados
1 -
1
de 1
1
Próxima >
>>